During the past decade, Somogy Megyei Kaposi Mor Oktato Korhaz conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 39 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 28 clinical trials were completed. i.e. 90.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Somogy Megyei Kaposi Mor Oktato Korhaz" #1 sponsor was "Pfizer" with 11 trials, followed by "Somogy Megyei Kaposi Mór Teaching Hospital" with 9 trials sponsored, "Celgene" with 8 trials sponsored, "Bayer" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Somogy Megyei Kaposi Mor Oktato Korhaz" #1 collaborator was "AbbVie" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Pharma Patent Kft." with 2 trials as a collaborator and "University Medical Center Groningen" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Somogy Megyei Kaposi Mor Oktato Korhaz" are "Primary Myelofibrosis" (6 trials), "Acute Myeloid Leukemia" (4 trials), "Parkinson Disease" (4 trials), "Multiple Myeloma" (3 trials) and "Myelofibrosis" (3 trials). Many other conditions were trialed in "Somogy Megyei Kaposi Mor Oktato Korhaz" in a lesser frequency.

Most popular intervention types in "Somogy Megyei Kaposi Mor Oktato Korhaz" are "Drug" (86 trials), "Other" (13 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Lenalidomide" (5 trials), "Pembrolizumab" (4 trials), "Rituximab" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Somogy Megyei Kaposi Mor Oktato Korhaz" are 101 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Somogy Megyei Kaposi Mor Oktato Korhaz". undefined are not yet recruiting, 20 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Somogy Megyei Kaposi Mor Oktato Korhaz, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Somogy Megyei Kaposi Mor Oktato Korhaz, 3 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 11 trials that are defined as “Not Applicable".